|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-1-21
|
|
pubmed:abstractText |
The effect of renin inhibition on type 2 diabetes is still unclear. The present study was undertaken to examine the efficacy of aliskiren, a direct renin inhibitor, on cardiovascular injuries, glucose intolerance and pancreatic injury in a mouse model of type 2 diabetes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1432-0428
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
180-91
|
|
pubmed:meshHeading |
pubmed-meshheading:19894030-Amides,
pubmed-meshheading:19894030-Animals,
pubmed-meshheading:19894030-Antihypertensive Agents,
pubmed-meshheading:19894030-Blood Pressure,
pubmed-meshheading:19894030-Body Weight,
pubmed-meshheading:19894030-Diabetes Mellitus, Experimental,
pubmed-meshheading:19894030-Diabetes Mellitus, Type 2,
pubmed-meshheading:19894030-Diabetic Angiopathies,
pubmed-meshheading:19894030-Fumarates,
pubmed-meshheading:19894030-Glucose Intolerance,
pubmed-meshheading:19894030-Hydralazine,
pubmed-meshheading:19894030-Mice,
pubmed-meshheading:19894030-Mice, Inbred C57BL,
pubmed-meshheading:19894030-Mice, Inbred Strains,
pubmed-meshheading:19894030-Obesity,
pubmed-meshheading:19894030-Organ Size,
pubmed-meshheading:19894030-Pancreas,
pubmed-meshheading:19894030-Renin
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes.
|
|
pubmed:affiliation |
Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Kumamoto 860-8556, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
